<DOC>
	<DOCNO>NCT01442311</DOCNO>
	<brief_summary>Drug user account disproportionately large burden hepatitis C virus ( HCV ) infection . However , HCV treatment adherence rate drug user may suboptimal patient use drug regularly HCV treatment . Because HCV treatment effective patient adhere least 80 % prescribed treatment regimen , intervention improve HCV treatment adherence need develop evaluate . The investigator design HCV DOT trial test efficacy two version modify directly observe HCV therapy provide on-site methadone clinic . The primary objective trial determine whether enhanced DOT pegylated interferon alfa-2a plus ribavirin ( PEG/RBV-DOT ) efficacious standard DOT weekly provider-administered pegylated interferon ( PEG-DOT ) self-administered ribavirin increase adherence improve HCV treatment outcomes . The investigator hypothesize PEG/RBV-DOT associate increased adherence rate sustain viral response compare PEG-DOT .</brief_summary>
	<brief_title>Directly Observed Hepatitis C Treatment Methadone Clinics</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>HCVinfected receive HCV medical care methadone clinic plan initiate HCV treatment onsite within next 3 month psychiatrically stable determined HCV treatment provider and/or onsite psychiatrist attend methadone clinic three six day per week receive methadone stable dose fo methadone two week prior baseline visit unable unwilling provide inform consent currently receive HCV treatment primary HCV care provider agree participation trial psychiatrically unstable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Methadone</keyword>
	<keyword>Injection Drug User</keyword>
	<keyword>Adherence</keyword>
	<keyword>Directly Observed Treatment</keyword>
</DOC>